DisclosureWe earn commission on partner links; ranking is set by clinician-vetted methodology — not advertisers.
GLP-1s improve PCOS metabolic features and cycle regularity. "Ozempic babies" phenomenon: patients on GLP-1s conceive unexpectedly as fertility improves.
Multiple small RCTs: 5-10% weight loss + improved HOMA-IR + reduced free testosterone. Cycle regularity improves in 40-60% of PCOS patients at 6 months. Conception rate increases — hence the "Ozempic babies" reports.
OB/GYN, reproductive endocrinology. Discussion in Endocrine Society 2026 guidelines.
STOP GLP-1s at least 2 months before trying to conceive (and immediately if pregnant) — animal data shows fetal harm. Birth control essential during use.
For PCOS + obesity, GLP-1s are increasingly first-line off-label. See /conditions/pcos for prescribing detail. Plan contraception carefully.
Editorial summary. Off-label use is legal but not FDA-evaluated. Insurance typically does not cover off-label prescriptions. Not medical advice.